Skip to Main Content

Author Details

Noah E Berlow
Children's Cancer Therapy Development Institute
2011
40
12
PMIDPaper TitleJournal TitlePublished Year
37916971Translational Aspects of Epithelioid Sarcoma: Current Consensus.Clin Cancer Res2024
37916971Translational Aspects of Epithelioid Sarcoma: Current Consensus.Clin Cancer Res2024
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
34693628Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.Pediatr Blood Cancer2022
35839307Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology.Clin Transl Med2022
35449398Machine learning for rhabdomyosarcoma histopathology.Mod Pathol2022
35578013Correction to: Machine learning for rhabdomyosarcoma histopathology.Mod Pathol2022
35820279Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1.Biochem Biophys Res Commun2022
34693628Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.Pediatr Blood Cancer2022
35839307Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology.Clin Transl Med2022
35578013Correction to: Machine learning for rhabdomyosarcoma histopathology.Mod Pathol2022
35820279Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1.Biochem Biophys Res Commun2022
35449398Machine learning for rhabdomyosarcoma histopathology.Mod Pathol2022
33436392Refractory alveolar rhabdomyosarcoma in an 11-year-old male.Cold Spring Harb Mol Case Stud2021
34172087Correction to: Design considerations of an IL13Rα2 antibody-drug conjugate for difuse intrinsic pontine glioma.Acta Neuropathol Commun2021
34013206Receptor-driven invasion profiles in diffuse intrinsic pontine glioma.Neurooncol Adv2021
34001278Design considerations of an IL13Rα2 antibody-drug conjugate for diffuse intrinsic pontine glioma.Acta Neuropathol Commun2021
33722797Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma.Cold Spring Harb Mol Case Stud2021
33436392Refractory alveolar rhabdomyosarcoma in an 11-year-old male.Cold Spring Harb Mol Case Stud2021
33708626Defining the Extracellular Matrix of Rhabdomyosarcoma.Front Oncol2021
34857796Preclinical therapeutics ex ovo quail eggs as a biomimetic automation-ready xenograft platform.Sci Rep2021
34661991Probabilistic Boolean Modeling of Pre-clinical Tumor Models for Biomarker Identification in Cancer Drug Development.Curr Protoc2021
33708626Defining the Extracellular Matrix of Rhabdomyosarcoma.Front Oncol2021
33722797Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma.Cold Spring Harb Mol Case Stud2021
34857796Preclinical therapeutics ex ovo quail eggs as a biomimetic automation-ready xenograft platform.Sci Rep2021
34661991Probabilistic Boolean Modeling of Pre-clinical Tumor Models for Biomarker Identification in Cancer Drug Development.Curr Protoc2021
34013206Receptor-driven invasion profiles in diffuse intrinsic pontine glioma.Neurooncol Adv2021
34172087Correction to: Design considerations of an IL13Rα2 antibody-drug conjugate for difuse intrinsic pontine glioma.Acta Neuropathol Commun2021
34001278Design considerations of an IL13Rα2 antibody-drug conjugate for diffuse intrinsic pontine glioma.Acta Neuropathol Commun2021
32532875Case report for an adolescent with germline RET mutation and alveolar rhabdomyosarcoma.Cold Spring Harb Mol Case Stud2020
32014859Undifferentiated small round cell sarcoma in a young male: a case report.Cold Spring Harb Mol Case Stud2020
32014486In vitro benchmarking of NF-κB inhibitors.Eur J Pharmacol2020
32238403Defining an embryonal rhabdomyosarcoma endotype.Cold Spring Harb Mol Case Stud2020
32532875Case report for an adolescent with germline RET mutation and alveolar rhabdomyosarcoma.Cold Spring Harb Mol Case Stud2020
32565715Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma.Sarcoma2020
32014859Undifferentiated small round cell sarcoma in a young male: a case report.Cold Spring Harb Mol Case Stud2020
32014486In vitro benchmarking of NF-κB inhibitors.Eur J Pharmacol2020
32238403Defining an embryonal rhabdomyosarcoma endotype.Cold Spring Harb Mol Case Stud2020
32565715Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma.Sarcoma2020
31113472Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.Skelet Muscle2019
31741706Volasertib preclinical activity in high-risk hepatoblastoma.Oncotarget2019
31208434Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.BMC Cancer2019
31113472Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.Skelet Muscle2019
30947707Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.BMC Cancer2019
31741706Volasertib preclinical activity in high-risk hepatoblastoma.Oncotarget2019
31208434Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.BMC Cancer2019
30947707Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.BMC Cancer2019
29621254IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.PLoS One2018
30459282The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma.Sci Signal2018
  • 1 - 50 of 80

Recommended Authors

Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 3
Sebastian Brabetz
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2016
Number of shared co-authors 5
Leylah M Drusbosky
College of Medicine, University of Florida
Career Start Year 2015
Number of shared co-authors 1
Patricia Jaaks
Wellcome Sanger Institute
Career Start Year 2015
Number of shared co-authors 1
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 6
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 4
Elizabeth Stewart
St Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 7
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 0
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Joseph A Ludwig
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 5
Christine A Pratilas
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 0
Jonathan R Dry
Present Address: Tempus Labs Inc.
Career Start Year 2003
Number of shared co-authors 2
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 2
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1998
Number of shared co-authors 6
Mathew J Garnett
Wellcome Sanger Institute
Career Start Year 1998
Number of shared co-authors 1
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 0
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Javed Khan
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 20
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 0
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 5
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 3
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 4
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Charles Keller
Children's Cancer Therapy Development Institute
Co-authored papers 35
Ranadip Pal
Texas Tech University
Co-authored papers 14
Matthew N Svalina
University of Colorado Anschutz Medical Campus
Co-authored papers 11
Atiya Mansoor
Oregon Health & Science University
Co-authored papers 10
Joel E Michalek
University of Texas Health Science Center
Co-authored papers 9
Jinu Abraham
Oregon Health & Science University
Co-authored papers 7
Megan M Cleary
Children's Cancer Therapy Development Institute
Co-authored papers 4
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 4
Lin Qi
Xiangya Hospital of Central South University
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Martin Goros
University of Texas Health San Antonio
Co-authored papers 3
Xiao-Nan Li
Northwestern University
Co-authored papers 3
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers 3
Paul T Spellman
Oregon Health & Science University Hospital.
Co-authored papers 3
Ken Kikuchi
Kyoto Prefectural University of Medicine
Co-authored papers 2
Javad Nazarian
USA University of Zurich
Co-authored papers 2
Mathew Geltzeiler
Co-authored papers 2
Eric H Raabe
Co-authored papers 2
Elaine Huang
Oregon Health and Science University, 3710 SW US Veterans Hospital Rd
Co-authored papers 2
Katherine E Warren
Co-authored papers 2
Maryam Fouladi
Co-authored papers 2
Marta M Alonso
CIMA-Universidad de Navarra
Co-authored papers 2
Jack F Shern
Co-authored papers 2
Carol J Bult
The Jackson Laboratory Cancer Center
Co-authored papers 2
Jacques Grill
Co-authored papers 2
Thomas G P Gr??newald
German Cancer Research Center
Co-authored papers 2
Eric Wang
Co-authored papers 2
Michelle Monje
Co-authored papers 2
Nathalène Truffaux
Co-authored papers 2
Ayeza Bajwa
Children's Cancer Therapy Development Institute
Co-authored papers 2
Release 1.2